rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2011-9-9
|
pubmed:databankReference |
|
pubmed:abstractText |
The study objectives were to 1) evaluate medication adherence for adults with attention-deficit/hyperactivity disorder (ADHD) treated with 3 times daily (TID) mixed amphetamine salts immediate release (MAS IR) versus once-daily (qAM) MAS extended release (MAS XR) in a randomized, crossover study; and 2) to examine the associations between adherence and efficacy for MAS IR and MAS XR.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1941-9260
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
123
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
71-9
|
pubmed:meshHeading |
pubmed-meshheading:21904088-Adolescent,
pubmed-meshheading:21904088-Adult,
pubmed-meshheading:21904088-Amphetamine,
pubmed-meshheading:21904088-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:21904088-Central Nervous System Stimulants,
pubmed-meshheading:21904088-Cross-Over Studies,
pubmed-meshheading:21904088-Female,
pubmed-meshheading:21904088-Humans,
pubmed-meshheading:21904088-Male,
pubmed-meshheading:21904088-Medication Adherence,
pubmed-meshheading:21904088-Middle Aged,
pubmed-meshheading:21904088-Psychiatric Status Rating Scales,
pubmed-meshheading:21904088-Treatment Outcome,
pubmed-meshheading:21904088-Young Adult
|
pubmed:year |
2011
|
pubmed:articleTitle |
Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study.
|
pubmed:affiliation |
Department of Psychiatry, NYU School of Medicine, New York, NY 10016, USA. lenard.adler@nyumc.org
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|